These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36503914)

  • 21. Minimum Information for Conducting and Reporting
    Subramaniam S; Joyce P; Ogunniyi AD; Dube A; Sampson SL; Lehr CM; Prestidge CA
    ACS Infect Dis; 2024 Feb; 10(2):337-349. PubMed ID: 38295053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies.
    Singh A; Amod A; Pandey P; Bose P; Pingali MS; Shivalkar S; Varadwaj PK; Sahoo AK; Samanta SK
    Biomed Mater; 2022 Feb; 17(2):. PubMed ID: 35105823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivery systems for potential treatment of intracellular bacterial infections.
    Imbuluzqueta E; Gamazo C; Ariza J; Blanco-Prieto MJ
    Front Biosci (Landmark Ed); 2010 Jan; 15(2):397-417. PubMed ID: 20036827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria.
    Khan F; Pham DTN; Kim YM
    Appl Microbiol Biotechnol; 2020 Mar; 104(5):1955-1976. PubMed ID: 31970432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic-cell-penetrating peptide conjugates targeting challenging drug-resistant and intracellular pathogenic bacteria.
    Zeiders SM; Chmielewski J
    Chem Biol Drug Des; 2021 Nov; 98(5):762-778. PubMed ID: 34315189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
    Galhano J; Marcelo GA; Duarte MP; Oliveira E
    Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of antibiotics with polymeric particles.
    Xiong MH; Bao Y; Yang XZ; Zhu YH; Wang J
    Adv Drug Deliv Rev; 2014 Nov; 78():63-76. PubMed ID: 24548540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection.
    Bhatia E; Banerjee R
    J Mater Chem B; 2020 Jun; 8(22):4890-4898. PubMed ID: 32285904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.
    Toti US; Guru BR; Hali M; McPharlin CM; Wykes SM; Panyam J; Whittum-Hudson JA
    Biomaterials; 2011 Sep; 32(27):6606-13. PubMed ID: 21652065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bioinspired hierarchical nanoplatform targeting and responding to intracellular pathogens to eradicate parasitic infections.
    Yu Y; Li J; Zhang Y; Ma Z; Sun H; Wei X; Bai Y; Wu Z; Zhang X
    Biomaterials; 2022 Jan; 280():121309. PubMed ID: 34896862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photochemical Internalization as a New Strategy to Enhance Efficacy of Antimicrobial Agents Against Intracellular Infections.
    Zhang X; de Boer L; Zaat SAJ
    Methods Mol Biol; 2022; 2451():671-689. PubMed ID: 35505040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.
    Uddin TM; Chakraborty AJ; Khusro A; Zidan BRM; Mitra S; Emran TB; Dhama K; Ripon MKH; Gajdács M; Sahibzada MUK; Hossain MJ; Koirala N
    J Infect Public Health; 2021 Dec; 14(12):1750-1766. PubMed ID: 34756812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria.
    Li W; Tailhades J; O'Brien-Simpson NM; Separovic F; Otvos L; Hossain MA; Wade JD
    Amino Acids; 2014 Oct; 46(10):2287-94. PubMed ID: 25141976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.
    Monteiro KLC; Silva ON; Dos Santos Nascimento IJ; Mendonça Júnior FJB; Aquino PGV; da Silva-Júnior EF; de Aquino TM
    Curr Top Med Chem; 2022; 22(24):1983-2028. PubMed ID: 35319372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenges and applications of nanotechnology against bacterial resistance.
    Lei Z; Karim A
    J Vet Pharmacol Ther; 2021 May; 44(3):281-297. PubMed ID: 33277732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?
    Zhang L; Liang E; Cheng Y; Mahmood T; Ge F; Zhou K; Bao M; Lv L; Li L; Yi J; Lu C; Tan Y
    Biomed Pharmacother; 2020 Aug; 128():110184. PubMed ID: 32450528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.